Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Grove Collaborative Holdings (GROV) Cash & Equivalents (2021 - 2025)

Grove Collaborative Holdings' Cash & Equivalents history spans 5 years, with the latest figure at $8.9 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 82.45% year-over-year to $8.9 million; the TTM value through Sep 2025 reached $8.9 million, down 82.45%, while the annual FY2024 figure was $19.6 million, 77.29% down from the prior year.
  • Cash & Equivalents for Q3 2025 was $8.9 million at Grove Collaborative Holdings, down from $10.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $132.4 million in Q2 2022 and bottomed at $8.9 million in Q3 2025.
  • The 5-year median for Cash & Equivalents is $78.6 million (2021), against an average of $66.3 million.
  • The largest annual shift saw Cash & Equivalents grew 9.71% in 2023 before it crashed 87.65% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $78.4 million in 2021, then grew by 3.46% to $81.1 million in 2022, then rose by 6.57% to $86.4 million in 2023, then tumbled by 77.29% to $19.6 million in 2024, then tumbled by 54.62% to $8.9 million in 2025.
  • Per Business Quant, the three most recent readings for GROV's Cash & Equivalents are $8.9 million (Q3 2025), $10.0 million (Q2 2025), and $9.6 million (Q1 2025).